Styrax Pharma Private Limited, a active private limited company, was established on 10 July 1995 in Vishakapatnam, Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230AP1995PTC098146. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹13.12 Cr.
Formerly known as Vaya Jayanthi Drugs Private Limited. It upholds a compliant status. Employing 260 professional, Its leadership includes Sreenath Suryadevara (Director), Lakshmi Devi Suryadevara (Director), Suryadevara Venkateswara Rao (Managing Director). Past directors included Viswanadha Raju Penmatsa, Sreenath Suryadevara, Lakshmi Devi Suryadevara. It holds ₹187.82 Cr open charges and ₹163.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 27B J. N. Pharmacity, Parawada, Vishakapatnam, Vishakapatnam, Andhra Pradesh, 531021.
U24230AP1995PTC098146
098146
10 July 1995
₹15.00 Cr
₹13.12 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Styrax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenath Suryadevara | Director | 18 Apr 2019 | Current |
| Lakshmi Devi Suryadevara | Director | 18 Apr 2019 | Current |
| Suryadevara Venkateswara Rao | Managing Director | 23 Jun 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 May 2014 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 25 Jul 2017 | Past |
| Pramod Abcsdd | Managing Director | 01 Apr 2008 | Past |
| Pramod Abcsdd | Director | 06 Nov 2014 | Past |
| Pramod Abcsdd | Director | 21 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Styrax Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a slight improvement in profitability, with a 1.69% increase in profit. The company's net worth Soared by an impressive increase of 16.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Styrax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,878,161,681.00
₹1,636,830,743.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2023 | Others | ₹45.00 Cr | Open |
| 29 Mar 2023 | Yes Bank Limited | ₹20.00 Cr | Open |
| 29 Mar 2023 | Yes Bank Limited | ₹1.50 Cr | Open |
| 23 Mar 2023 | Axis Bank Limited | ₹20.80 Cr | Open |
| 01 Mar 2023 | Others | ₹35.00 Cr | Open |
Explore comprehensive loan charge details -
Styrax Pharma has a workforce of 260 employees as of Dec 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Styrax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 35.00 Cr registered on 01 Mar 2023 with Charge ID 100682072 was modified on 23 Apr 2025. was recorded as a recent event.
Progress on A charge registered on 17 Jul 2023 via Charge ID 100749047 with Others was fully satisfied on 28 Mar 2025. was documented.
The activity A charge with Others of Rs. 45.00 Cr registered on 04 Oct 2023 with Charge ID 100803552 was modified on 29 Nov 2024. was completed.
The activity A charge registered on 31 Mar 2021 via Charge ID 100440801 with Others was fully satisfied on 16 Oct 2024. was completed.
Progress on A charge registered on 18 Nov 2019 via Charge ID 100305933 with Others was fully satisfied on 16 Oct 2024. was documented.
Styrax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Styrax Pharma Private Limited is U24230AP1995PTC098146.
Styrax Pharma Private Limited is headquartered at Plot No. 27B J. N. Pharmacity, Parawada, Vishakapatnam, Vishakapatnam, Andhra Pradesh, 531021.
Styrax Pharma Private Limited was incorporated on 10 July 1995.
The current directors of Styrax Pharma Private Limited are
The primary industry of Styrax Pharma Private Limited is Manufacturing.
Styrax Pharma Private Limited is unlisted.
The authorized capital of Styrax Pharma Private Limited is ₹15.00 Cr, and the paid-up capital is ₹13.12 Cr.
The compliance status of Styrax Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX